EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factors

By de Wit R.   Pawinsky A.   Stoter G.   van Oosterom A.T.   Fossa S.D.   Paridaens R.   Svedberg A.   de Mulder P.H.M.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 493-495

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of sorafenib in advanced renal cell carcinoma patients: Results from a long-term study

By            

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 935-939

Spandidos Publications

Access to resources Recommend Favorite

Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer: results of a phase II study

By Schuler M.   Bruntsch U.   Spath-Schwalbe E.   Schrezenmeier H.   Peschel C.   Farber L.   Burger K.J.   Leiszner J.   Huber C.   Aulitzky W.E.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 754-756

Elsevier

Access to resources Recommend Favorite

Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group

By van Wijk F.H.   Lhomme C.   Bolis G.   Scotto di Palumbo V.   Tumolo S.   Nooij M.   de Oliveira C.F.   Vermorken J.B.  

European Journal of Cancer, Vol. 39, Iss. 1, 2003-01 ,pp. : 78-85

Elsevier

Access to resources Recommend Favorite

Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group

By Aapro M.S.   van Wijk F.H.   van der Burg M.E.L.   ten Bokkel Huinink W.   Vergote I.   Guastalla J.P.   Rosso R.   Kobierska A.   Beex L.V.A.   Namer M.   Splinter T.E.W.   Vermorken J.B.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1141-1143

Elsevier

Access to resources Recommend Favorite